Oxford Immunotec Global PLC Ordinary Shares
OXFD
OXFD was delisted on the 5th of March, 2021.
62 hedge funds and large institutions have $249M invested in Oxford Immunotec Global PLC Ordinary Shares in 2015 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 21 increasing their positions, 23 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
2% more funds holding
Funds holding: 61 → 62 (+1)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
1% less capital invested
Capital invested by funds: $251M → $249M (-$2.15M)
9% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 23
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$2.66M |
| 2 |
PC
Polar Capital
London,
United Kingdom
|
+$2.38M |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$1.7M |
| 4 |
GPGA
Grandeur Peak Global Advisors
Salt Lake City,
Utah
|
+$1.44M |
| 5 |
Axa
Paris,
France
|
+$1.27M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WSA
Wall Street Associates
Lajolla,
California
|
-$3.22M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$2.5M |
| 3 |
TCM
Tamarack Capital Management
Carlsbad,
California
|
-$1.76M |
| 4 |
DM
Deerfield Management
New York
|
-$563K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$416K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BA
51
BlackRock Advisors
Wilmington,
Delaware
| $120K | -$16.5K | -1,216 | -12% |
|
52
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $75K | +$9.72K | +717 | +15% |
|
53
Morgan Stanley
New York
| $57K | +$52.9K | +3,900 | +1,250% |
|
54
BNP Paribas Financial Markets
Paris,
France
| $53.9K | +$31.4K | +2,319 | +138% |
|
55
Royal Bank of Canada
Toronto,
Ontario, Canada
| $13K | -$2.2K | -162 | -15% |
|
56
UBS Group
Zurich,
Switzerland
| $11K | -$1.71K | -126 | -14% |
|
57
BlackRock
New York
| $4K | – | – | – |
|
58
Citigroup
New York
| $1K | -$119K | -8,771 | -99% |
|
59
Bank of America
Charlotte,
North Carolina
| $1K | -$6.86K | -506 | -88% |
|
60
Barclays
London,
United Kingdom
| $1K | -$3.79K | -280 | -73% |
|
61
Bank of Montreal
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
62
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $196 | +$7.47K | +551 | +4% |
|
|
CS
63
Credit Suisse
Zurich,
Switzerland
| – | -$183K | -13,234 | Closed |
|
64
Citadel Advisors
Miami,
Florida
| – | -$20K | -1,442 | Closed |
|
|
TRCT
65
Tower Research Capital (TRC)
New York
| – | -$1K | -65 | Closed |
|
OXFD Hedge Fund Activity: Q3 2015 in Review
62 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global PLC Ordinary Shares (OXFD) for Q3 2015, worth a combined $249M — down 0.86% from $251M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new OXFD positions and 3 closed out — a net gain of 1 holder — while 21 added to existing stakes and 23 trimmed.
The largest buyer was Waddell & Reed Financial, opening a new position worth an estimated $2.66M. The largest seller was Wall Street Associates, cutting an estimated $3.22M.
- 62 institutional investors held Oxford Immunotec Global PLC Ordinary Shares (OXFD) as of Q3 2015, up from 61 in Q2 2015.
- Funds reported $249M of Oxford Immunotec Global PLC Ordinary Shares stock for Q3 2015, down 0.86% quarter-over-quarter.
- 4 funds opened new Oxford Immunotec Global PLC Ordinary Shares positions in Q3 2015 and 3 closed out, a net change of +1 holder.
- The largest Oxford Immunotec Global PLC Ordinary Shares buyer in Q3 2015 was Waddell & Reed Financial, an estimated $2.66M added.
- The largest Oxford Immunotec Global PLC Ordinary Shares seller in Q3 2015 was Wall Street Associates, an estimated $3.22M sold.
Based on aggregated 13F filings for Q3 2015.